Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Francisca Vogelaar

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|January 19, 2023
Interleukin-4 as a therapeutic targetYvonne Gärtner, Lynn Bitar, Frauke Zipp, et al.
European Journal of Pharmacology|January 22, 2020
Targeting CD52 does not affect murine neuron and microglia functionErik Ellwardt, Christina Francisca Vogelaar, Carlos Maldet, et al.
Plos One|July 30, 2015
Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In VivoChristina Francisca Vogelaar, Brigitte König, Stefanie Krafft, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2010
High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cellsSeema Dangwal, Bernhard H Rauch, Thomas Gensch, et al.
Journal of Neurotrauma|December 14, 2019
The Cerebral Thrombin System Is Activated after Intracerebral Hemorrhage and Contributes to Secondary Lesion Growth and Poor Neurological Outcome in C57Bl/6 MiceHarald Krenzlin, Eva Gresser, Daniel Jussen, et al.
The Journal of Experimental Medicine|March 29, 2020
CNS-localized myeloid cells capture living invading T cells during neuroinflammationBeatrice Wasser, Dirk Luchtman, Julian Löffel, et al.
Science Translational Medicine|October 29, 2025
Bruton's tyrosine kinase inhibitors rescue neuronal impairment caused by B cell-mediated lymphotoxin-α releaseJosef Shin, Paul Götz, Nesrin Sharif, et al.
The Journal of Experimental Medicine|May 19, 2022
Interleukin-4 receptor signaling modulates neuronal network activityNicholas Hanuscheck, Carine Thalman, Micaela Domingues, et al.
Nature Neuroscience|September 28, 2018
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitisErik Ellwardt, Gautam Pramanik, Dirk Luchtman, et al.
Nature Neuroscience|November 9, 2018
Publisher Correction: Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitisErik Ellwardt, Gautam Pramanik, Dirk Luchtman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|January 19, 2023
Interleukin-4 as a therapeutic targetYvonne Gärtner, Lynn Bitar, Frauke Zipp, et al.
European Journal of Pharmacology|January 22, 2020
Targeting CD52 does not affect murine neuron and microglia functionErik Ellwardt, Christina Francisca Vogelaar, Carlos Maldet, et al.
Plos One|July 30, 2015
Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In VivoChristina Francisca Vogelaar, Brigitte König, Stefanie Krafft, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2010
High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cellsSeema Dangwal, Bernhard H Rauch, Thomas Gensch, et al.
Journal of Neurotrauma|December 14, 2019
The Cerebral Thrombin System Is Activated after Intracerebral Hemorrhage and Contributes to Secondary Lesion Growth and Poor Neurological Outcome in C57Bl/6 MiceHarald Krenzlin, Eva Gresser, Daniel Jussen, et al.
The Journal of Experimental Medicine|March 29, 2020
CNS-localized myeloid cells capture living invading T cells during neuroinflammationBeatrice Wasser, Dirk Luchtman, Julian Löffel, et al.
Science Translational Medicine|October 29, 2025
Bruton's tyrosine kinase inhibitors rescue neuronal impairment caused by B cell-mediated lymphotoxin-α releaseJosef Shin, Paul Götz, Nesrin Sharif, et al.
The Journal of Experimental Medicine|May 19, 2022
Interleukin-4 receptor signaling modulates neuronal network activityNicholas Hanuscheck, Carine Thalman, Micaela Domingues, et al.
Nature Neuroscience|September 28, 2018
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitisErik Ellwardt, Gautam Pramanik, Dirk Luchtman, et al.
Nature Neuroscience|November 9, 2018
Publisher Correction: Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitisErik Ellwardt, Gautam Pramanik, Dirk Luchtman, et al.
Pageof 2